Circulatory adipocytokines and lipid profile variations in type-2 diabetic subjects: Desirable side-effects of antidiabetic drugs

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 8, Issue 4, 2014, Pages 230-232

  Ghadge, Abhijit A ^a   Harke, Shubhangi M ^a   Khadke, Suresh P ^a   Diwan, Arundhati G ^b   Pankaj, Madhu ^b   Kulkarni, Omkar P ^a   Ranjekar, Prabhakar K ^a   Kuvalekar, Aniket A ^a  

^a Bharati Vidyapeeth   (India)

^b Bharati Vidyapeeth's Medical College   (India)

Author keywords

Adipocytokines; Antidiabetic drugs; Blood pressure; Lipid profile; T2DM

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLIMEPIRIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN; METFORMIN; PIOGLITAZONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ADIPOCYTOKINE; ANTIDIABETIC AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; SEX DIFFERENCE; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; INDIA; INSULIN RESISTANCE; MIDDLE AGED; POSTPRANDIAL STATE; TREATMENT OUTCOME;

ADIPOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INDIA; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 84916606097     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.09.010     Document Type: Article

References (18)

1. C.M. Maya-Monteiro, P.E. Almeida, H. D'Avila, A.S. Martins, A.P. Rezende, and H. Castro-Faria-Neto Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase and mammalian target of rapamycin-dependent mechanism J Biol Chem 28 2008 2203 2210
2. D. Richard, A.C. Carpentier, G. Dore, V. Ouellet, and F. Picard Determinants of brown adipocyte development and thermogenesis Int J Obes 34 2010 S59 S66
3. J.M. Friedman, and J.L. Halaas Leptin and the regulation of body weight in mammals Nature 395 1998 763 770
4. J.Y. Kim, S.V. Ahn, J.H. Yoon, S.B. Koh, J. Yoon, and B.S. Yoo Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study Diabetes Care 36 2013 1547 1553
5. L. Sewon, and K. Hyo-Bum Role of adiponectin in metabolic and cardiovascular disease J Exerc Rehabil 10 2 2014 54 59
6. M.N. Pham, H. Kolb, T. Mandrup-Poulsen, T. Battelino, J. Ludvigsson, and P. Pozzilli Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin Diab Metab Res Rev 29 2 2013 166 170
7. H.S. Assal, M. Fath-Allah, and A. Elsherbiny Serum leptin and adiponectin in obese diabetic and non-diabetic J Med Sci 7 5 2007 865 869
8. M. Ryo, T. Nakamura, S. Kihara, M. Kumada, S. Shibazaki, and M. Takahashi Adiponectin as a biomarker of the metabolic syndrome Circ J 68 11 2004 975 981
9. B. Keidan, J. Hsia, and R. Kat Plasma lipids and antidiabetic agents: a brief overview Br J Diabetes Vasc Dis 2 2002 40 43
10. L.M. Blanco-Colio, J.L. Martín-Ventura, C. Gómez-Guerrero, X. Masramon, E. Teresa, and C. Farsang Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk Eur J Pharmacol 586 2008 259 265
11. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation Diabet Med 15 1998 539 553
12. N. Rasouli, U. Raue, L.M. Miles, T. Lu, G.B. Gregorio, and S.C. Elbein Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue Am J Physiol Endocrinol Metab 288 2005 E930 E934
13. W.S. Lin, H.M. Chang, T.Y. Tai, and L.M. Chuang Effect of thiazolidinedione on gene expression in NIH3T3-L1 adipocytes Diabetes 48 1 1999 A217
14. R.W. Whitcomb, and A.R. Saltiel Thiazolidinediones Expert Opin Investig Drugs 12 1995 1299 1309
15. U.B. Pajvani, M. Hawkins, T.P. Combs, M.W. Rajala, T. Doebber, and J.P. Berger Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity J Biol Chem 279 2004 12152 12162
16. L.G. Fryer, A. Parbu-Patel, and D. Carling The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways J Biol Chem 277 2002 25226 25232
17. N.K. Lebrasseur, M. Kelly, T.S. Tsao, S.R. Farmer, A.K. Saha, and N.B. Ruderman Thiazolidinediones can rapidly activate AMP-activated protein kinase (AMPK) in mammalian tissues Am J Physiol Endocrinol Metab 291 2006 E175 E181
18. N.A. El-Ghaffar, and N.H. El-Said Hypoadiponectinaemia in Egyptian patients with type II diabetes mellitus with vascular complications J Med Sci 6 4 2006 626 630